[{"NetIncomeLoss_2_Q2_USD":-218651000.0,"DepreciationAndAmortization_2_Q2_USD":7692000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":50564000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":24347000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":177755000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":178327000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":2348000.0,"InterestPaidNet_2_Q2_USD":9742000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":715000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":354805000.0,"AssetsCurrent_0_Q2_USD":1151968000.0,"OtherNoncashIncomeExpense_2_Q2_USD":782000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":543631000.0,"ContractWithCustomerLiability_0_Q2_USD":4281000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":9584000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":5773000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":7826000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":2567000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":7688000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":8555000.0,"Assets_0_Q2_USD":1594878000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":1720000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":7592000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":131458000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":8952000.0,"Liabilities_0_Q2_USD":338638000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":96436000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":860330000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-104000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":13543000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":5191000.0,"AccountsReceivableNetCurrent_0_Q2_USD":47245000.0,"RepaymentsOfSeniorDebt_2_Q2_USD":250000000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":344000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":144000.0,"CommonStockValue_0_Q2_USD":18000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":172166000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":12469000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-230880000.0,"CostsAndExpenses_2_Q2_USD":310760000.0,"CostsAndExpenses_1_Q2_USD":126556000.0,"OtherAssetsCurrent_0_Q2_USD":37770000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-81000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-216931000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-72408000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":425000.0,"OtherAssetsNoncurrent_0_Q2_USD":1413000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":58206000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":141633000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":3338876000.0,"Cash_0_Q2_USD":6071000.0,"SeniorNotesCurrent_0_Q2_USD":0.0,"ResearchAndDevelopmentExpense_2_Q2_USD":205423000.0,"InterestReceivableCurrent_0_Q2_USD":6100000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":99420000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-218307000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-79856000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":24396000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-847000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-96000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-161978000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":1681000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2_Q2_USD":41700000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1_Q2_USD":41700000.0,"LiabilitiesCurrent_0_Q2_USD":123958000.0,"AccountsPayableCurrent_0_Q2_USD":19246000.0,"NonoperatingIncomeExpense_2_Q2_USD":-6967000.0,"NonoperatingIncomeExpense_1_Q2_USD":-2147000.0,"InterestExpense_2_Q2_USD":6851000.0,"InterestExpense_1_Q2_USD":647000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":58206000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":19120000.0,"StockIssuedDuringPeriodSharesShareBasedCompensation_2_Q2_shares":49000.0,"StockIssuedDuringPeriodSharesShareBasedCompensation_1_Q2_shares":0.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":11424000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":27214000.0,"ContractWithCustomerAssetNotPastDue_0_Q2_USD":25000000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":61372000.0,"NetIncomeLoss_1_Q2_USD":-80000000.0,"Goodwill_0_Q2_USD":76501000.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":3790000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_2_Q2_USD":86700000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":48847000.0,"OperatingIncomeLoss_2_Q2_USD":-211340000.0,"OperatingIncomeLoss_1_Q2_USD":-77709000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":980191000.0,"InventoryNet_0_Q2_USD":12584000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":1757000.0,"PreferredStockValue_0_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1594878000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":22548000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":48607000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":23371000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":15139000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":2133000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.23,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.45,"ProfitLoss_2_Q2_USD":-218651000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":2239000.0,"StockholdersEquity_0_Q2_USD":1256240000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":2524000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":3594000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-2083369000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-38157000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":10443000.0,"CommonStockSharesOutstanding_0_Q2_shares":178810000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q2_USD":42100000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-3790000.0,"Ticker":"NKTR","CIK":"906709","name":"NEKTAR THERAPEUTICS","OfficialName":"Nektar Therapeutics  Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"862449342.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200807"}]